Product Information
AZP-531 is a drug that has been shown to have pharmacokinetic properties and pharmacodynamics in humans. It has a terminal half-life of about 7 hours, which is shorter than the half-life of most drugs. AZP-531 binds to the myocardium and mesentery and can be used to treat metabolic disorders such as obesity. This drug has also been shown to inhibit protein synthesis in animals, but not humans. The drug was well-tolerated by healthy volunteers with no serious adverse effects reported. AZP-531 is an analog of rapamycin, a macrolide antibiotic that was originally developed for cancer therapy but was found ineffective for this purpose. Rapamycin inhibits cell growth by binding to the immunophilin FKBP12, which prevents the mTOR kinase from associating with its substrate S6K1 and phosphorylating it. AZP-531 may have potential as an anti-cancer agent
Chemical properties
Technical inquiry about: 3D-NTB54362 AZP-531
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
